Branded Prescription Drug Fee; Correction Documents
Branded Prescription Drug Fee; Correction
 

Table of Contents Back to Top

Written or electronic comments and requests for a public hearing for the notice of proposed rulemaking by cross-reference to temporary regulations published at 79 FR 43699, June 28, 2014, are still being accepted and must be received by October 27, 2014.

FOR FURTHER INFORMATION CONTACT: Back to Top

Celia Gabrysh at (202) 317-6855 (not a toll free number).

SUPPLEMENTARY INFORMATION: Back to Top

Background Back to Top

The notice of proposed rulemaking by cross-reference to temporary regulations (REG-123286-14) that is the subject of these corrections is under section 9008 of the Patient Protection and Affordable Care Act.

Need for Correction Back to Top

As published, the notice of proposed rulemaking by cross-reference to temporary regulations (REG-123286-14) contains an error that may prove to be misleading and is in need of clarification.

Correction of Publication Back to Top

Accordingly, the notice of proposed rulemaking by cross-reference to temporary regulations (REG-123286-14), that was the subject of FR Doc. 2014-17698, is corrected as follows:

On page 43699, in the preamble, second column, under the caption ADDRESSES, the twelfth line from the bottom of the column, the language “delivered to: CC:PA:LPD:PR Monday” is corrected to read “delivered Monday”.

Martin V. Franks,

Chief, Publications and Regulations Branch, Legal Processing Division, Associate Chief Counsel (Procedure and Administration).

[FR Doc. 2014-22928 Filed 9-25-14; 8:45 am]

BILLING CODE 4830-01-P